A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Relapsing Multiple Sclerosis

Interventions

OTHER

No intervention

Trial Locations (2)

RECRUITING

PROVIDE Virtual Research Coordination Center, San Francisco

RECRUITING

PROVIDE Virtual Research Coordination Center, Wilmington

All Listed Sponsors

lead

TG Therapeutics, Inc.

INDUSTRY

NCT06143514 - A Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk | Biotech Hunter | Biotech Hunter